Lantern Pharma Inc. SEC filings LTRN

Lantern Pharma Inc. has 262 filings in SEC EDGAR's recent list, going back to Jan 14, 2019. Its latest annual report, Form ARS, was filed on Oct 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (listing notice). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Oct 21, 2026 Dec 31, 2025
10-K/A Amended annual report Apr 30, 2026 Dec 31, 2025
10-K Annual report Mar 30, 2026 Dec 31, 2025
ARS Annual report to shareholders Aug 11, 2025 Dec 31, 2024
10-K/A Amended annual report Apr 30, 2025 Dec 31, 2024
10-K Annual report Mar 27, 2025 Dec 31, 2024
ARS Annual report to shareholders May 3, 2024 Dec 31, 2023
10-K Annual report Mar 18, 2024 Dec 31, 2023
ARS Annual report to shareholders May 5, 2023 Dec 31, 2022
10-K Annual report Mar 20, 2023 Dec 31, 2022
10-K Annual report Mar 10, 2022 Dec 31, 2021
10-K Annual report Mar 10, 2021 Dec 31, 2020

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LTRN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
TX
Headquarters
Dallas, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1763950
Former names
Lantern Pharma (until Jan 14, 2019)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.